VBCG
MRTX

Valley Brook Capital Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Valley Brook Capital Group’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-200
Closed -$34K – 457
2021
Q1 		$34K Hold
200
– – 0.03% 261
2020
Q4 		$43K Buy
+200
New +$43K 0.04% 210